Top Markets
#1 EXOD EXOD +22.08%
#2 Status Status +11.36%
#3 The Bitcoin Bull The Bitcoin Bull +5.66%
#4 Tornado Cash Tornado Cash +5.29%
#5 BCGame Coin BCGame Coin +5.00%
#6 B3 (Base) B3 (Base) +4.43%
#7 MarsCoin MarsCoin +3.79%
#8 Gas Gas +3.76%
#9 Fake World Assets Fake World Assets +3.61%
#10 The Black Bull The Black Bull +3.12%
Coin of the day
EXOD EXOD
Innstillinger
Språk
NORSK
Valuta
USD
Tema
LAVA Therapeutics N.V. LAVA Therapeutics N.V.

LAVA Therapeutics N.V.

LVTX
Rangering i aksjer #25847
LAVA Therapeutics N.V. is an immuno-oncology firm, currently in the clinical... LAVA Therapeutics N.V. is an immuno-oncology firm, currently in the clinical development phase, dedicated to pioneering novel therapies for cancer. Utilizing its proprietary Gammabody platform, the company engineers innovative bispecific antibodies. These antibodies are specifically designed to engage and harness the potent and precise capabilities of gamma delta T cells, aiming to stimulate a robust anti-tumor immune response and ultimately enhance outcomes for individuals battling cancer. Key compounds in its clinical pipeline include LAVA-051, currently undergoing Phase 1/2a trials for various hematologic malignancies such as chronic lymphocytic leukemia, multiple myeloma, and acute myeloid leukemia. Another front-runner, LAVA-1207, is also in Phase 1/2a clinical studies, targeting metastatic castration-resistant prostate cancer. Furthermore, LAVA Therapeutics is advancing additional Gammabody candidates: LAVA-1223, an investigational treatment for specific solid tumors that targets the epidermal growth factor receptor (EGFR), and preclinical assets LAVA-1266 and LAVA-1278, intended for a range of blood cancers. The company has also forged a research collaboration and licensing partnership with Janssen Biotech, Inc. This alliance focuses on the potential discovery and development of multi-specific antibody therapies aimed at a particular target across diverse therapeutic applications. Established in 2016, LAVA Therapeutics N.V. operates from its headquarters in Utrecht, the Netherlands.
Aksjekurs
$1.74
Sist synkronisert: 2025-11-28
Markedsverdi
$45.77M
Endring (1 dag)
0.00%
Endring (1 år)
13.73%
Land
NL
Handel LAVA Therapeutics N.V. (LVTX)

Kategori

Healthcare
Aksjeprishistorikk for LAVA Therapeutics N.V. (LVTX)
Høyeste sluttskurs: $1.68 den 2025-11-01

Laveste sluttskurs: $13.74 den 2021-03-01
Aksjeprishistorikk for LAVA Therapeutics N.V. fra 2021 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -5.21%
2025 33.22%
2024 -17.20%
2023 -67.44%
2022 -17.89%
2021 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 35.65%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $120.74 -16.83%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 8.65%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 397.46%
US